Keymed Biosciences, Inc. Financial Overview
Keymed Biosciences, Inc.'s market cap is currently HK$16.31B. The company's EPS TTM is HK$-0.327949137; its P/E ratio is ―; Keymed Biosciences, Inc. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
